Digene Files Patent Suit Against Third Wave

Law360, New York (January 12, 2007, 12:00 AM EST) -- Digene Corp. has filed a patent infringement lawsuit against Third Wave Technologies Inc. over a test for a human papillomavirus that can cause cancer.

Digene makes the only U.S. Food and Drug Administration-approved test that detects human papillomavirus 52.

According to Digene's complaint, filed Thursday, Third Wave’s Invader HPV A9 Oligo Mix infringes Digene’s patent on its test. The complaint said the infringement has occurred since at least Oct. 11, 2005.

A Third Wave spokesman did not return phone messages for comment.

Digene is seeking an...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.